Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients database.
about
Multidisciplinary Canadian consensus recommendations for the management and treatment of hepatocellular carcinomaContribution of alpha-fetoprotein in liver transplantation for hepatocellular carcinomaSelection Criteria and Current Issues in Liver Transplantation for Hepatocellular CarcinomaLiver transplantation for hepatocellular carcinoma beyond the Milan criteria: A reviewSelection of patients with hepatocellular carcinoma for liver transplantation: Past and futurePrediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantationRole of liver transplantation for hepatocellular carcinomaRecent advances in multidisciplinary management of hepatocellular carcinomaToward a better liver graft allocation that accounts for candidates with and without hepatocellular carcinomaRole of positron emission tomography/computed tomography in living donor liver transplantation for hepatocellular carcinomaLiver transplantation for advanced hepatocellular carcinomaIdentifying candidates with favorable prognosis following liver transplantation for hepatocellular carcinoma: Data mining analysis.Neo-adjuvant therapy for hepatocellular carcinoma before liver transplantation: where do we stand?A scoring model based on neutrophil to lymphocyte ratio predicts recurrence of HBV-associated hepatocellular carcinoma after liver transplantationCurrent status of the organ replacement approach for malignancies and an overture for organ bioengineering and regenerative medicine.Combination of morphologic criteria and α-fetoprotein in selection of patients with hepatocellular carcinoma for liver transplantation minimizes the problem of posttransplant tumor recurrence.Systematic review: the prognostic role of alpha-fetoprotein following liver transplantation for hepatocellular carcinoma.An evidence-based multidisciplinary approach to the management of hepatocellular carcinoma (HCC): the Alberta HCC algorithmPrognostic prediction across a gradient of total tumor volume in patients with hepatocellular carcinoma undergoing locoregional therapyCurrent and future challenges in the surgical treatment of hepatocellular carcinoma: a review.The Indian National Association for Study of the Liver (INASL) Consensus on Prevention, Diagnosis and Management of Hepatocellular Carcinoma in India: The Puri Recommendations.Validating posttransplant hepatocellular carcinoma recurrence data in the United Network for Organ Sharing database.Hepatocellular carcinoma: clinical frontiers and perspectives.Predictive value of pre-transplant platelet to lymphocyte ratio for hepatocellular carcinoma recurrence after liver transplantation.Transarterial chemoembolization in patients with hepatocellular carcinoma: predictors of survival.Long-term outcomes of hepatic resection versus living donor liver transplantation for hepatocellular carcinoma: a propensity score-matching study.Intermediate hepatocellular carcinoma: How to choose the best treatment modality?Incidence and risk factors of hepatocellular carcinoma recurrence after liver transplantation in the MELD era.Managements of recurrent hepatocellular carcinoma after liver transplantation: A systematic review.Selection tool alpha-fetoprotein for patients waiting for liver transplantation: How to easily manage a fractal algorithm.Alpha-fetoprotein and novel tumor biomarkers as predictors of hepatocellular carcinoma recurrence after surgery: a brilliant star raises again.Alpha-fetoprotein: a controversial prognostic biomarker for small hepatocellular carcinomaFactors predicting survival after post-transplant hepatocellular carcinoma recurrenceLiver transplantation for hepatocellular carcinoma: analysis of factors predicting outcome in 1074 patients in OPTN Region 5.Alpha-fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria.Validation of the Model of End-Stage Liver Disease for Liver Transplant Allocation in Alberta: Implications for Future Directions in Canada.Incidence, Characteristics, and Prognosis of Incidentally Discovered Hepatocellular Carcinoma after Liver Transplantation"Metroticket" predictor for assessing liver transplantation to treat hepatocellular carcinoma: a single-center analysis in mainland China.Liver transplantation for small hepatocellular carcinoma.Living donor liver transplantation for hepatocellular carcinoma at the University of Tokyo Hospital.
P2860
Q24635267-F85E70A4-3045-4C08-B9C6-629013FCB1B5Q26740332-795DD167-C7F0-4063-9D35-CE19928D0583Q26744102-7365A5B9-E112-4524-A0FF-28F38FAB3A2CQ26750463-87F60D66-7A95-42A2-A084-47453DD1678FQ26771246-F4D2174F-48E5-40AA-B2A1-8D9A34AA00FDQ26772329-84BCB485-DCA6-42BB-A861-6F9122114E04Q26822581-CB979DFF-03A2-4324-9737-8F1F40D84732Q26863748-79ADFFC8-3501-42CC-8C1A-89FCF4437BCDQ26999411-70B84720-B077-41CA-B310-612B79257F5CQ28067010-5E6D2264-C47C-415F-9EC9-2D27827AF096Q28074653-03A78DE9-9CFD-4134-BB73-69BB588D8C5CQ30962577-73D1BADB-6BD6-4371-A8C9-B010D4CF707DQ33594862-F2D982A1-273E-40C6-A54D-A1756DC33AEFQ34038193-7D24E34F-2FB9-4FDB-9618-F55DC54C6D94Q34135201-33EA59E5-D7F1-44AB-8495-95CBADD74E98Q34169336-3AA781E7-BC2C-4E5C-8643-8BAA7EC20B9DQ34201437-9EED17F2-8116-4278-B0A1-F4B045750D0CQ34417009-A81DBFD5-5823-4017-BF40-360A7933FC9AQ34498762-5058F986-BFFD-4624-93FE-DCCFD6675058Q34623730-F53D023D-7CDD-4D37-A3BF-E680FF983D4DQ34826535-375761DB-CD0D-48D0-A2EC-47C5A8F588C1Q34987874-5EC894FA-36EC-4EA7-9947-7CD31A0D3BD9Q35112053-F51985E0-7E16-4744-ACCD-B7E502DF80BEQ35114617-9B4BF62D-1871-45B8-8F41-387217A72D20Q35268118-297AC311-8DEE-4249-934A-B4A33D713EE9Q35422169-E8539E46-55F9-43D3-AB56-72F3463161FDQ35626764-E1B4FBEC-D7B5-494E-B4D1-C851783C5481Q35785027-97374940-230A-4771-856E-9B114E75186DQ35818336-BBABE211-8F80-4846-B259-733ECEAB0DA3Q35895358-3B213541-9992-46C7-86C9-9449F7383AA6Q36082480-F77BE00B-61F7-4DB4-A5D3-65D63B0E6D6AQ36561634-31FC30F9-6253-4B1E-9F52-6C37901760F4Q36662813-72012164-C355-4D07-8CEE-AFDF4DE001E2Q36702287-2BD8836E-227C-4A3C-804C-AAA9640A0B17Q36728731-2EE12035-0EB4-4109-B3D2-70FCE95C57D8Q36997090-07D42FF8-B384-4DEF-8B6C-3B6248ACEFBAQ37049395-BEA3928C-812D-4A17-9EF7-F6722BAE6B5FQ37358673-A03A87F9-8E60-45DC-9CDF-4C54415B221EQ37360177-9A8287CB-0100-4E4C-86EA-516B0EC79236Q37360183-1DAE65D4-41BD-4419-9DFC-04933EA178CB
P2860
Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients database.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Reassessing selection criteria ...... ransplant Recipients database.
@en
Reassessing selection criteria ...... ransplant Recipients database.
@nl
type
label
Reassessing selection criteria ...... ransplant Recipients database.
@en
Reassessing selection criteria ...... ransplant Recipients database.
@nl
prefLabel
Reassessing selection criteria ...... ransplant Recipients database.
@en
Reassessing selection criteria ...... ransplant Recipients database.
@nl
P2093
P2860
P356
P1433
P1476
Reassessing selection criteria ...... ransplant Recipients database.
@en
P2093
A M James Shapiro
Christian Toso
David L Bigam
Norman M Kneteman
Sonal Asthana
P2860
P304
P356
10.1002/HEP.22693
P407
P577
2009-03-01T00:00:00Z